Metro, Inc. (OTCPK:MTRAF) Q4 2022 Earnings Conference Call November 16, 2022 9:00 AM ET
Company Participants
Sharon Kadoche – Manager of Investor Relations & Treasury
Eric La Flèche – President & Chief Executive Officer
François Thibault – Executive Vice President & Chief Financial Officer
Conference Call Participants
George Doumet – Scotiabank
Vishal Shreedhar – National Bank
Michael Van Aelst – TD Securities
Peter Sklar – BMO Capital Markets
Chris Li – Desjardins
Operator
Good morning, ladies and gentlemen, and welcome to the Metro Inc. 2022 Fourth Quarter Results Conference Call. [Operator Instructions] This call is being recorded on November 16, 2022.
I would now like to turn the conference over to Sharon Kadoche, Manager, Investor Relations and Treasury. Please go ahead.
Sharon Kadoche
Thank you, Julie, and good morning, everyone, and thank you for joining us today. Our comments will focus on the financial results of our fourth quarter, which ended on September 24. With me today is Mr. Eric La Flèche, President and CEO; and François Thibault, Executive VP and CFO. During the call, we will present our fourth quarter results and comment on its highlights. We will then be happy to take your questions.
Before we begin, I would like to remind you that we will use in today’s discussion different statements that could be construed as forward-looking information. In general, any statement which does not constitute a historical fact may be deemed as a forward-looking statement. Expressions such as expect, intend, are confident that, will and other similar expressions are generally indicative of forward-looking statements. The forward-looking statements are based upon certain assumptions regarding the Canadian food and pharmaceutical industries, the general economy and our annual budget as well as our 2022/2023 action plan. These forward-looking statements do not provide any guarantees as to the future performance of the company and are subject to potential risks, known and unknown as well as uncertainties that could cause the outcome to differ materially. A description of these risks, which could have an impact on these statements, could be found under the Risk Management section of our 2021 Annual Report.
As with the preceding risks, the COVID-19 pandemic constitutes a risk that could have an impact on the business, operations, projects, synergies and performance of the company. We believe these statements to be reasonable and pertinent at this time and represent our expectations. The company does not intend to update any forward-looking information, except as required by applicable law.
I will now turn the call over to François.
François Thibault
Thank you, Sharon, and good morning, everyone. Before I begin the review of the quarter, I want to highlight a few changes we made in the MD&A and the financial statements. So the MD&A reflects the new requirements with respect to non-GAAP and other financial measures. And you’ll see additional to the effect in Pages 10 and 11 of the interim report and Page 5 of the press release. We also took the opportunity to provide more details in the consolidated statements of income. So cost of goods sold, gross profit and operating expenses, which were previously disclosed in the note additional information on the nature of earnings are not presented separately in the consolidated statements of income.
Gains or losses from the disposal of assets have been reclassified from operating expenses and are presented on a separate line in the consolidated statements of income and impairment charges are also reclassified from operating expenses. And if important, are presented separately in the income statement or otherwise will be part of the depreciation expense.
So turning to the quarter; total sales were $4.4 billion, an increase of 8.3% over last year, and food same-store sales increased by a strong 8% for the quarter, while pharma same-store sales were up 7.4%. Our gross margin stood at 20.4% of sales, stable versus same quarter last year. For the year, food gross margin came down slightly but was compensated by stronger margins in our Pharmacy division, resulting in stable gross margin overall for fiscal 2022.
During the quarter, we recorded $7.1 million of impairments of assets, net of reversals, including $60 million resulting from our decision to have Jean Coutu withdraw from the Air Miles Volt program in the spring of 2023. This impairment of $60 million represents the entire carrying value of the Jean Coutu loyalty program assets and is an adjusting item for net earnings and EPS. The remaining $10.1 million represents mostly impairment of right-of-use assets. Furthermore, we recorded $11.2 million of gains on the disposal of assets, mostly real estate. So operating expenses stood at $476.1 million or 10.7% of sales versus 10.5% of sales in the corresponding quarter last year. The increase is due mainly to inflationary pressures on costs, namely labor, transportation, energy and supplies.
EBITDA for the quarter totaled $441.4 million, up 9.4% year-over-year. And as a percentage of sales, EBITDA was 10% versus 9.9% last year. Excluding the gains on sale of assets of $11.2 million this quarter and the small one last year, EBITDA grew 7% and represented 9.7% of sales versus 9.8% last year. Adjusted net earnings were $219.4 million compared to $20.6 million last year, an increase of 9.4% and our adjusted net earnings per share amounted to $0.92, up 13.6% versus last year’s adjusted EPS of $0.81. And — at the close of fiscal 2022, capital expenditures amounted to $621 million, an increase of $22 million versus last year. And for 2023, we are planning to invest a record level of CapEx of about $800 million, resulting mainly from our ongoing investments in the modernization of our supply chain in both provinces.
On the retail side, we opened 5 new stores this year, including one conversion. We also relocated a Metro store and carried out major renovations in 17 stores, representing a net increase of 141,000 square feet or 0.7% of our food retail network.
Turning to in-store technology. We ended the year with 454 stores equipped with self-checkout, and we plan on adding another 60 in the coming year. As for electronic shelf labels, we ended the year with 243 stores, and we plan on adding another 85 this year. We completed our annual normal course issuer bid program on November 8, repurchasing a total of 7 million shares for a total consideration of $482 million, representing an average share price of $68.81.
In closing, the company announced its support for the task force on climate-related financial disclosure. So we aim to increase the resilience of our business to address physical and transition climate-related risk by continuing to integrate climate risk and opportunities into our governance, strategy, risk management and metrics and targets as recommended by the CCFD. We’re convinced that a combined approach to climate change mitigation and resilience will be beneficial to all our stakeholders.
That’s it for me. I’ll turn it over to Eric.
Eric La Flèche
Thank you, François, and good morning, everyone. Our ’22 fiscal year ended with a solid performance in the fourth quarter as our teams worked very hard to offer products at competitive prices in the current high inflation environment, which we know is difficult for many consumers. Our diversified business model allowed us to maintain stable gross margins in the quarter while delivering good value to our customers as reflected in overall tonnage growth and market share gains in the quarter, driven mainly by our discount banners.
Total sales grew by 8.3%, as François said, and adjusted EPS by 13.6%. Food same-store sales were up 8% in the quarter compared to a decrease of 2.9% for the same quarter last year when most pandemic restrictions were lifted. The 3-year stack is 15.4% or 4.9% CAGR. Our internal food basket inflation accelerated to 10%, up from 8.5% in the prior quarter as the industry continues to experience unprecedented increases in cost of goods sold. Traffic was up, while the average basket remained flat. Promotional penetration continues to increase as consumers look for the best value. 2 weeks ago, we opened our 100th Super C store in Saint Jerome north of Montreal, a significant milestone for us and the store is off to a great start. Pharmacy comparable sales were up 7.4% with a 6.4% increase in prescription drugs helped by COVID-related activities such as the distribution of rapid tests. Front store sales were up 9.9%, supported by strong growth in over-the-counter medications, cosmetics and seasonal merchandise.
Turning to online; sales were up 33% for the quarter, driven by added capacity through our partnerships as well as the expansion of Click and Collect. We started to deploy Click & Collect service at our Super C stores in Quebec, and we plan on rolling out the service to most of those stores by the end of the fiscal year. On September 27, we announced the launch of Moa, an evolution of Metro Imua, our loyalty program in the province of Quebec. While we’ll capitalize on the strength and complementary nature of our food and pharmacy networks where more than 95% of Quebec households already shop. Our new loyalty program will also include a co-branded Visa card with RBC, and we are very excited about this new partnership. The program will provide customers more opportunities to earn points and integrated digital experience and enhanced personalization in close to 900 locations across our Metro Super Ci, Jean Coutu, Brunet and Premier Moscone in Quebec. We look forward to launching the program next spring.
Turning to our supply chain investments; we are pleased with the productivity gains at our new frozen distribution center in Toronto. The additional capacity of the new freezer has also enabled a reduction in direct-to-store deliveries from certain vendors, resulting in efficiency gains and a better in-stock position at store level. Work on the new fully automated fresh and frozen facility in Tecan is advancing well, and the startup is scheduled before the end of the 23 fiscal year. Construction of the second phase of our fresh distribution center in Toronto is being completed as we speak, and the installation of the automation equipment will begin in January. The operations start date has been pushed by 6 months to the spring of 2024.
Looking forward, we continue to face market uncertainties, labor shortages and a higher-than-normal cost inflation. We expect food inflation to moderate in the new year as we will start to cycle the high inflation of 2022, but the inflation outlook remains uncertain as we continue to receive many vendor requests for price increases in February. That said, we are confident that our dedicated teams, multiple banners, strong private label offering, effective weekly promotions and loyalty programs position us well to meet the needs of our customers as we navigate through this period of turbulence.
And finally, next month, Metro will celebrate its 75th anniversary. We are proud of our roots, our success over the long term and our renewed purpose to nourish the health and well-being of the communities we serve.
Thank you. And we’ll be happy to take your questions.
Question-and-Answer Session
Operator
Thank you. Ladies and gentlemen, we will now begin the question-and-answer session. [Operator Instructions] Your first question comes from George Doumet from Scotiabank.
George Doumet
I’m just wondering to what extent of the outperformance of the discount banners kind of accelerate from last quarter? Or was it pretty stable? Anything you can share maybe in terms of trade down happening within the conventional stores?
Eric La Flèche
Well, as I said in my opening remarks, customers are searching for value that is accelerating the discount shift. So we’ve been talking about it for a few quarters. It continued to accelerate in the past quarter from conventional to discount. The good thing is we are very well positioned in both Quebec and Ontario with our discount banners, and that’s driving a lot of our growth and gains. So happy about that. Conventional banners. Metro stores continue to do well. There is a search for value in those stores for sure also. So private label penetration continues to increase. We have aggressive promotional strategy and are trying to serve our customers as best we can in this high inflation environment. But to answer your question, the discount shift accelerated in Q4 relative to the past two quarters.
George Doumet
On the OpEx rate, I believe it’s up 20 bps. You guys usually run a tight ship. So can you maybe talk a little bit about where that pressure is coming from? And maybe how should we think of that kind of run rate for next year?
François Thibault
Yes. So yes, there was some inflationary pressures on OpEx, mainly labor, transportation, energy supplies. Those were the categories where we saw an increase in sales versus sales versus last year, sorry. So yes, this quarter, it was a bit of a catch-up in inflation. So inflation is not just in gross margin. The there’s inflation in our OpEx. And so that’s our job. We — our job is to make sure that we contain it as much as possible. But this quarter, yes, there was a bit of catch-up and pressure on the OpEx.
George Doumet
Okay. And just one last one, maybe for you, François. On the CapEx line, it seems to be kind of trending higher as well as a percentage of sales. I think you called it $800 million of CapEx for next year. Can you maybe just talk general trends of CapEx maybe above and beyond next year? And just maybe give us a little bit of sense of what’s in the $800 million bucket?
François Thibault
Yes, it’s mostly — well, there’s no reduction in our retail network investments, so that continues. The increase over normal levels, if you will, is the modernization of our supply chain. So it’s all the automated automation of our DCs in Ontario and Quebec. So you should expect 2023 and 2024 to be at higher-than-normal levels, and then it should taper off somewhat as we move into 2025, 2026. So this is not new, it’s planned for. But that explains the main variations.
Operator
Your next question comes from Mark Petrie from CIBC.
Unidentified Analyst
This is Kunal [ph] filling in for Mark. First, I wanted to know if you could please talk about the impact of inflation on your front store comp numbers. Earlier this year, we indicated that front store inflation was at more normal levels in the 2% range. So I just wanted to know if you could share how that has evolved as the year has progressed? And where do you see that trending into fiscal ’23? And if you could talk about which category that’s seen the most inflation that would be great as well.
Eric La Flèche
Thank you. So yes, there’s inflation in the health and beauty products also. So that has increased. The increase in inflation is broad-based, but clearly at lower levels than on the food side. That said, there are products that are common between food and pharmacy, and that’s having an impact on the general inflation of health and beauty. So the health — our inflation for health and beauty is in the 5% range. So that is fueling some of the growth in front store sales. However, I would say the main driver is COVID-related COVID-like symptoms, cough and cold or COVID-like symptoms are driving traffic for OTC products and general traffic to our stores, which is helpful to our front-end sales. So pleased with our performance on an absolute and relative basis over there.
Unidentified Analyst
Okay, that’s great. And then my follow-up is on the launch of the new loyalty program next spring. Should we expect a slight ramp in marketing expenses around the launch in the spring and once it is in market, do you expect the program to operate much differently versus what you have now in terms of customer engagement and incentivized behavior?
Eric La Flèche
So yes, you can expect some launch costs. Any time you launch a major program like that, there’s going to be some marketing and we will have onetime expenses, but nothing material or that we will manage with. So we’re — we’ll take care of that. And like I said, the program is an evolution of [indiscernible]; it will include all of our banners, food and pharma. So a renewed technological platform more and better personalization. So I think there’s going to be more there for the customer, more chance to earn the points with the co-branded credit card, they can accumulate points more points on all their purchases elsewhere outside of our networks that can be redeemed in our networks. So we think that it’s going to be well received by our customers as an added benefit. And for us, it will be a better tool to personalize our merchandising.
Operator
Your next question comes from Vishal Shreedhar from National Bank.
Vishal Shreedhar
I just wanted a bit more detail, François. If you could, on that $10 million impairment on store assets. Is that — is this going to be a frequently recurring type of thing? Like how often should we expect this?
François Thibault
No, it’s not — there’s always some small ups and downs every quarter that we basically don’t mention because it’s not important. And in any event, it’s always flagged in the cash flow statement. But when it is important, we did flag it in the past, and now we want to make sure that it’s included in a separate line, so to give you more visibility. But it’s not — that level is not a common amount every quarter, every end of the year, we look at all our assets, we make impairment tests, and it happens that sometimes we have to have to make it write-off. So that’s what happened today. But it’s not a — that’s not a run rate number. In any event, we will — as I said, we will continue to flag it to make sure that you can compare apples-to-apples.
Vishal Shreedhar
Okay. And just changing gears here to the while loyalty program and might be still early days for this question, but wondering how Metro is thinking about how Ontario fits in to this loyalty change? And if there’s any thoughts there.
Eric La Flèche
Well, it’s something we’re going to evaluate and consider. So we’re really focused on getting a good launch in Quebec, and then we’ll see what we do next in Ontario. So something we’re going to be evaluating and determining at a later date, and we’ll keep you posted for now. We have a relationship with Armanta continues in Ontario.
Vishal Shreedhar
Okay. As Sean alluded to earlier, Metro has a disciplined approach to capital allocation, and there’s a proposed federal 2% buyback tax; details aren’t fully out. But wondering if management — if there’s any early thoughts on how management thinks about that and if it would alter its capital allocation considerations.
François Thibault
No, nothing that I’ve read would have us change our capital allocation, no change on that.
Vishal Shreedhar
And maybe just one last one here. Cybersecurity is a topical issue. Is there anything that Metro could do if needed to further enhance protection? And how should Metro think about the risks and potential cost increases, if necessary, to increase defenses.
Eric La Flèche
So this is something that we’ve been thinking about for a long time as most companies and all companies do. We think we have good defense, and we have good systems and good plans. But everybody is vulnerable and we are very mindful of that and to make sure our contingency plans are updated and tested. So we’re doing everything we can to mitigate the risk, but it’s a risk that’s out there that we have managed consistently, and we’ll try to continue to do the same. So extra cost, yes, fiber costs more every year than it has been for years. It’s a good part of our IT budget, and it will remain a good part of our IT budget. We have a dedicated team, and we make sure that we report to the audit commit, and the Board regularly on that. It is a topical subject. So we are paying a lot of attention, no question.
Operator
Your next question comes from Ken Ricky [ph] from ATB Capital Markets.
Unidentified Analyst
Eric, just in terms of your gross margin performance in the quarter, a modest increase on the various mix shifts. Can you provide some insight on gross margin in food versus pharmacy retail even just directionally? And then also the biggest driver of the margin change in each segment.
Eric La Flèche
Well, the — as François indicated, our gross margin overall is stable due to our diversified mix. So the short answer is gross margin in food is slightly down and gross margin in pharmacy is slightly up. And net-net, we came out pretty stable. On the food side, the search for value, the promotional penetration is putting pressure on gross margin. The other side of that is private label sales are doing really well, doing really well, and that’s good on the gross margin rate. So a lot of puts and takes and ups and downs, but shrink levels tend to vary in high inflationary times and produce when prices get out of whack and their sticker shock, there’s more shrink. So our teams are — like I said, working really hard to offer competitive prices and great weekly promotions to deliver value to our customers and to manage our gross margins as best we can.
So there’s pressure on the gross margin for sure due to cost of goods sold and our ability to pass those costs in our pricing. And we don’t pass it all at once or — and in some cases, we don’t pass it all at all. And we absorb some of those cost inflation because we want to be at a price that will attract customers and do the job to deliver value. So it’s — it takes experience managers, good merchandisers to build the pricing program, the promotional program and to come out with a margin that will deliver results. That said, there is pressure on the food side. I hope that helps?
Unidentified Analyst
It does, Eric. And then just on the topic of food inflation. We saw CPI numbers just hit the tape for October, very modest cooling, I think, 11% from 11.4% prior. Can you provide some insight just on how challenging it is has become to continue managing double-digit inflation? And also, are you seeing indications that inflation can continue to cool or perhaps you even see an acceleration of the cooling over the next number of months given all the various levers that have been pulled…
Eric La Flèche
Yes, for sure, double-digit 10% inflation or so is challenging. As I said, our ability to pass those cost increases through is very difficult. So I’m not going to repeat my previous answer, but careful management, experience management is required to manage through inflationary turbulence like this. As far as going forward, the cooling, we hope it will cool. We certainly expect — we don’t expect because we don’t know, we don’t have a crystal ball. There’s a lot of global phenomenon impacting food inflation globally. So hard for me to predict. But typically, historically, when we’ve had inflation peaks or higher inflation year-over-year, it tends to come down simply because of the supply and demand. So we expect that as we cycle high inflation in the next months and quarters, we expect year-over-year inflation on food to moderate. But I don’t want to say this is more hope than expectation, but it’s based on our experience. That’s what usually happens, but it doesn’t mean it will happen this year. It will be that we’ll see what the pressures are on global food supply and how our vendors or manufacturers are coming through.
Like I said in my opening statement, we still — we have continued to receive cost increases effective next February. We’re negotiating hard with our suppliers to mitigate that. We want them to justify that, and we’re pushing back as there is resistance for sure, from retailer, from customers and our ability to merchandise. So if the vendors want to keep the volumes, the cost decreases will have to moderate. So it’s a challenging time, and we’re managing through it.
Operator
Your next question comes from Michael Van Aelst from TD Securities.
Michael Van Aelst
A question on the rent store of the pharmacy. The beauty and cosmetics has been rebounding really strong over the past year. And I’m curious as to when you start cycling your tougher comps in these categories. And then on top of that, historically, what level of economic sensitivity have you seen in this category?
Eric La Flèche
Yes. So cosmetics have been doing well ever since the pandemic restrictions lifted basically and people start to socialize and return to the office or go out. So that was basically Q4 last year. And like you see today, we’re reporting good front store year-over-year. There’s a bit of inflation there, but there’s strong demand. So we’re confident that we can maintain that on the cosmetics side. The COVID symptoms or cough and coal, that’s another issue. But on the cosmetics, we’re pretty confident that, that will remain pretty strong. Even in recessionary times, our experience is that that’s a small pleasure that people will keep for us for as long as they can, and it’s not something that will be cut. So we’re confident that cosmetic sales can remain very healthy.
Michael Van Aelst
Okay, that’s helpful. And then you exited the UGI buying group, and I’m just curious why — what the rationale would be Brexit-ing [ph] it if there was no significant financial impact.
Eric La Flèche
Well, we — I think we have reached a scale that allows us to reach the same for more volume rebates that we were entitled with through UGI. So it’s just a question of more efficiency for us, more independent. Just we’re trying to simplify our business anytime we can. It was a great association for many, many years. It was helpful. But as we grow and as we evolve, we’re at a point now where we think we’re best to go on our own.
Michael Van Aelst
Does it require you to add more capabilities in-house then, and that’s offsetting some of that but maybe potentially better purchasing?
Eric La Flèche
Capabilities, I’m not sure I get it, but in terms…
Michael Van Aelst
Just buying capability like more in-house stamp for preferred procurement if you’re now buying…
Eric La Flèche
Our central procurement team handles all procurement basically and all the UGI association stuff. So they will have that less to do and focus directly to the vendors.
Michael Van Aelst
Okay. And finally, on the guidance, it’s a pretty — the outlook statement is relatively short, not completely unusual. But there’s no comment on long-term 8% to 10% EPS growth expectations or and definitely nothing for this year coming up. So I’m wondering, are you expecting growth in fiscal ’23 on an earnings standpoint? And maybe if you could discuss some of the high-level expectations, pluses and minuses in a bit more detail.
François Thibault
So Michael, I’ll just start by saying that we have not changed our annual growth targets, sales, 2% to 4%, operating income 4% to 6% and EPS 8% to 10%. Those have not changed. Those are medium long-term targets on an annual basis. So the outlook was not meant to give guidance. Yes, look, it was — yes, we give more detail on the outlook during the pandemic and where things were very, very uncertain volatile but no change in our growth targets.
Eric La Flèche
So we’ve never given guidance a little bit, like Francis said, our targets remain the same, and we’re confident that we can continue to grow.
François Thibault
Exactly.
Eric La Flèche
Thanks, Michael.
Operator
Your next question comes from Peter Sklar from BMO Capital Markets.
Peter Sklar
François, I just have a arithmetic question to start on the comp. So your comp was 8% for food. And I think you’re saying that your inflation you experienced was 10%, which doing the subtraction implies about negative 2% tonnage. But I think during your commentary and in the write-up, you’ve said you had positive tonnage growth. So I’m just wondering if you can reconcile the two.
François Thibault
Yes. No, you’re right. That simple equation works better when things are stable and when the inflation and sales are at lower amount. But at those levels, the math has a bit skewed, especially given the significant consumer shift to discount private label promotion. So that formula gets to be less precise. So we’ve had tonnage growth validated by external agencies and in fact, shows that we not only have we’ve grown well we’ve grown more than market. And we always validate our own shipments from warehouse and this quarter, they were up for the first time this year. So that’s why we were confident to say that our tonnage is up despite, yes, that simple arithmetic that would imply it’s down 2%.
Peter Sklar
Right. And also, you see the data that we don’t see the market share data that some of the consultants gather and sell to you. So — can you comment just a little bit, like how you think you’re doing in terms of market share in conventional and discount?
Eric La Flèche
So like I said in my opening statement, we’re very pleased with our market share performance in food. So we’re not going to segregate between discount and conventional, but overall, our market share is up, and we’re very pleased with that. And no secret that it’s driven by the discount growth.
Peter Sklar
Yes. Okay. And then just my last question, just back on cost pressure and vendors, et cetera. Look, I know we’re still inflating at a high level and the vendors are still asking for these increases. But kind of, I guess, you call it a second derivative effect is the rate of increases that they’re demanding — like is it starting to level off and diminish a little bit? Like are you seeing some of this beginning to tail off? Or is it just these cost pressures are continue to accelerate?
Eric La Flèche
Well, I wouldn’t say they accelerate, but they remain at elevated levels in terms of rates. So that’s what we’re challenging because in 2022, we accepted or we had to take several increases multiple times during the year at significant higher rates. So those that are coming back for more at higher rates, that’s why I said we’re pushing back on those. So it’s leveling off in terms of rates, and we hope that it will start to decline. So again, it’s our job to mitigate negotiate and protect our costs as much as we can. That said, vendors have pressures. They have cost increases, and we have to sit down with them and come to an understanding.
Operator
[Operator Instructions] Your next question comes from Chris Li from Desjardins.
Chris Li
Sorry if you made a touch on this earlier, but are you seeing any notable changes in the competitive environment? Or has it remained intense, but a rational overall?
Eric La Flèche
Yes. It remains very competitive, as always, intense rationale, yes, that still applies. With the accelerating discount shift, all other banners are trying to protect their share, their sales. So they are aggressive, very aggressive. And we will defend obviously, and we will do our own best to keep some decent sales and growth in conventional banners, but short answer, it’s very competitive.
Chris Li
Okay, that’s great. And maybe wondering also that you had a very strong quarter in terms of e-commerce sales way ahead of some of your peers. Can you talk a little bit about what drove performance? Is it mostly driven by capacity expansion? Or are you actually seeing some nice organic both within your existing customer base?
Eric La Flèche
It’s driven by additional capacity. That’s what I tried to point out in my opening statement. We have expanded click and collect. So that’s additional capacity. And we have signed a new — a second partnership. So we have two third-party delivery partners, Cornershop and Instacart, and that has contributed to the growth you see. On a same-store basis or the organic growth has been pretty flat. The total e-com market is flat or somewhat slightly declining. So our growth is driven by what I just said.
Chris Li
Okay, that’s helpful. And in terms of job vacancy, both in terms of pharmacists and warehouse employees, are you seeing any improvement on that front?
Eric La Flèche
It remains very challenging in parameter Quebec, especially labor shortages, frontline employees in the stores, a lot of open positions. So — and DCs, it remains challenging. Pharmacists and tech lab technicians; again, there’s pressure there. So the labor shortages, the situation has not changed. So it remains very challenging, something that’s structural and permanent for a while that we have to manage with. So doing a lot of work to attract, retain our people that has put some pressure on our own wages, but it’s a reality. So we have to fill those vacant positions as much as we can and working hard to do it.
Chris Li
Okay. And maybe a quick one for François. Just your CapEx is going up. Can you give us a sense of what we should pencil in for depreciation for next year? I think it was about $200 million for fiscal ’22? Just directionally, what’s a reasonable number for next year.
François Thibault
Sorry, Chris, I didn’t hear the first, but what went up?
Chris Li
With CapEx going up, I’m assuming depreciation is also going to go up next year as well. I’m just wondering if you can give us some guidance on what to pencil in for make sure for DNA.
François Thibault
Yes. So you’re right, CapEx will go up. So you should expect to see some impact on depreciation. I will say that most of those CapEx are in long-term assets in terms of the depreciation life. So it’s not going to be as impactful as the increase in CapEx may suggest. But you’ve seen an increase in depreciation this year. It’s going to be something similar to what we’ve seen this year. And we’re — as I said, we’re we do all this to have benefits, which our aim is certainly to compensate that and more on the OpEx side.
Chris Li
Okay. Thanks very much in the best guess.
Operator
Presenters, there are no further questions at this time. Please proceed.
Sharon Kadoche
Thank you all for your interest in METRO, and we will speak again soon to discuss our first quarter results on January 24. Thank you.
Operator
Ladies and gentlemen, this concludes your conference call for today. We thank you for joining and ask that you please disconnect your lines. Thank you.
Be the first to comment